AZ, Dentsply close to deal on Astra Tech

AstraZeneca is reportedly close to an agreement for selling its dental implant and medical device unit Astra Tech to Dentsply International for approximately $1.8 billion, said a person close to the deal. However, no deal has been reached and the talks may still fall apart, Bloomberg quotes the source as saying. News

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.